Quadrant Capital Group’s Evotec EVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.37K Sell
548
-678
-55% -$2.19K ﹤0.01% 2547
2025
Q4
$3.78K Sell
1,226
-3,624
-75% -$12.4K ﹤0.01% 2424
2025
Q3
$17.6K Buy
+4,850
New +$18.4K ﹤0.01% 1993
2025
Q2
Sell
-5,300
Closed -$17.7K 1750
2025
Q1
$17.7K Sell
5,300
-502
-9% -$2.05K ﹤0.01% 2067
2024
Q4
$24.1K Sell
5,802
-398
-6% -$1.67K ﹤0.01% 1805
2024
Q3
$22.6K Sell
6,200
-8,016
-56% -$31.8K ﹤0.01% 1843
2024
Q2
$68.2K Buy
14,216
+7,910
+125% +$44.4K 0.01% 1234
2024
Q1
$49.4K Buy
6,306
+4,176
+196% +$32.9K ﹤0.01% 1410
2023
Q4
$25K Buy
+2,130
New +$20.9K ﹤0.01% 1714
2022
Q4
Sell
-1,682
Closed -$15K 2767
2022
Q3
$15K Buy
1,682
+224
+15% +$2.67K ﹤0.01% 1688
2022
Q2
$17K Buy
1,458
+586
+67% +$7.66K ﹤0.01% 1390
2022
Q1
$13K Buy
+872
New +$14.9K ﹤0.01% 1529

Other funds holding EVO

Quadrant Capital Group's EVO Position: Q1 2026 in Review

Quadrant Capital Group reduced its Evotec (EVO) stake by 55% in Q1 2026, selling an estimated $2.19K and leaving 548 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #2547.

Quadrant Capital Group first reported a position in EVO in Q1 2022 and has held it in 12 quarters since. The position peaked at $68.2K in Q2 2024. 46 funds tracked by Wall St. Rank hold EVO as of Q1 2026.

  • Quadrant Capital Group held 548 shares of Evotec worth $1.37K as of Q1 2026.
  • Quadrant Capital Group sold 678 Evotec shares in Q1 2026, an estimated $2.19K.
  • Evotec made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2547 holding.
  • Quadrant Capital Group first reported a position in Evotec in Q1 2022 and has held it in 12 quarters since.
  • Quadrant Capital Group's Evotec position peaked at $68.2K in Q2 2024.
  • 46 funds tracked by Wall St. Rank held Evotec as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.